{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:12:12Z","timestamp":1774627932728,"version":"3.50.1"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Zhaqu Compound (ZQC), a traditional Chinese herbal formula, has shown promise in improving glucose and lipid metabolism, but its mechanisms in T2DM-MASLD remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, db\/db mice with T2DM-MASLD were treated for 12 weeks with ZQC, metformin, or saline. Metabolic outcomes included blood glucose, insulin resistance indices, lipid profiles, hepatic steatosis, hepatocyte ultrastructure, gut microbiota (16S rRNA), fecal metabolomics, and liver transcriptomics. In high-glucose + palmitate\u2013induced HepG2 cells, ZQC-containing serum and the PPAR\u03b3 agonist GW1929 were applied to assess gluconeogenic and lipogenic proteins.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      ZQC improved glycemia, insulin resistance, lipid profiles, and hepatic steatosis. Gut microbiota analysis showed modulation of key metabolic genera, including\n                      <jats:italic>Bacteroides, Mucispirillum, Lactobacillus, Lachnospiraceae<\/jats:italic>\n                      , and\n                      <jats:italic>Muribaculaceae<\/jats:italic>\n                      , with correlations to glucose, lipid, and hepatic biochemical indices. Metabolomics and transcriptomics revealed regulation of amino acid metabolism, AGE-RAGE\/mTOR pathways, and enrichment of hepatic PPAR\u03b3\u2013related pathways, alongside modulation of fatty acid and arachidonic acid metabolism. In HepG2 cells, ZQC reduced lipid accumulation, decreased triglycerides and cholesterol, enhanced glucose uptake, and restrained PPAR\u03b3 and its downstream transporters CD36 and FABP4. N-phenethylhexadecanamide, palmitic acid, and isoxanthohumol likely mediate these effects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Overall, ZQC improves glucose and lipid metabolism in T2DM with MASLD by modulating gut microbiota, influencing hepatic PPAR\u03b3\u2013related pathways, and enhancing hepatocyte metabolic function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1775686","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T15:22:01Z","timestamp":1774624921000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Zhaqu compound improves glucose and lipid metabolism in T2DM with MASLD by modulating gut microbiota and PPAR\u03b3"],"prefix":"10.3389","volume":"13","author":[{"given":"Yifan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yizhu","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjing","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchi","family":"He","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialong","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sihan","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]},{"name":"Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]},{"name":"Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1136\/gutjnl-2023-330110","article-title":"Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis","volume":"72","author":"En Li Cho","year":"2023","journal-title":"Gut"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.2337\/diabetes.53.suppl_3.s16","article-title":"Five stages of evolving beta-cell dysfunction during progression to diabetes","volume":"53","author":"Weir","year":"2004","journal-title":"Diabetes"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.3390\/ijms22094495","article-title":"Metabolic spectrum of liver failure in type 2 diabetes and obesity: from NAFLD to NASH to HCC","volume":"22","author":"Kim","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1007\/s00125-015-3712-7","article-title":"Gut microorganisms as promising targets for the management of type 2 diabetes","volume":"58","author":"Delzenne","year":"2015","journal-title":"Diabetologia"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1016\/j.clnu.2022.10.009","article-title":"Interplay between dietary intake, gut microbiota, and metabolic profile in obese adolescents: sex-dependent differential patterns","volume":"41","author":"Liu","year":"2022","journal-title":"Clin Nutr"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2717.e33","DOI":"10.1016\/j.cell.2024.03.034","article-title":"Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway","volume":"187","author":"Nie","year":"2024","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrendo.2015.128","article-title":"Short-chain fatty acids in control of body weight and insulin sensitivity","volume":"11","author":"Canfora","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"157519","DOI":"10.1016\/j.phymed.2025.157519","article-title":"Moronic acid alleviates non-alcoholic fatty liver disease and fibrosis through PPARs-mediated lipidomic reprogramming","volume":"149","author":"Han","year":"2025","journal-title":"Phytomedicine"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e70227","DOI":"10.1111\/1751-7915.70227","article-title":"Lactiplantibacillus plantarum attenuates diet-induced obesity and insulin resistance through gut microbiota-driven PPAR\/PI3K-Axis modulation","volume":"18","author":"Gao","year":"2025","journal-title":"Microb Biotechnol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1694242","DOI":"10.3389\/fphar.2025.1694242","article-title":"Multi-omics analysis elucidates the therapeutic mechanisms of the Quzhi formula in metabolic dysfunction-associated steatohepatitis targeting gut microbiota, lipid metabolism, and the role of its metabolite fraxin","volume":"16","author":"Wu","year":"2025","journal-title":"Front Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"34597","DOI":"10.1021\/acsomega.5c03364","article-title":"Integration of metabolomics, transcriptomics, and 16s rRNA sequencing reveals the mechanism of Morus alba L. (Sangzhi) alkaloids (SZ-A) in improving cholesterol metabolism in diabetic rats","volume":"10","author":"Li","year":"2025","journal-title":"ACS Omega"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"157197","DOI":"10.1016\/j.phymed.2025.157197","article-title":"Baicalin ameliorates high-fat diet induced MAFLD by inhibiting ERK\/PPAR\u03b3\/CD36 pathway","volume":"147","author":"Lei","year":"2025","journal-title":"Phytomedicine"},{"key":"ref14","first-page":"285","article-title":"Clinical effect and partial mechanism of Jiawei Zhaqu Yin in treating non-alcoholic fatty liver disease","volume":"19","author":"Zhou","year":"2013","journal-title":"Chin J Exp Tradit Med Formulae"},{"key":"ref15","first-page":"525","article-title":"Impact of Jia Wei Zha Qu Yin on FFA-CYP2E1-MDA path in the experimental non-alcoholic fatty liver disease rats","volume":"25","author":"Zhang","year":"2014","journal-title":"Lishizhen Med Mater Med Res"},{"key":"ref16","first-page":"1518","article-title":"Impact of Jiawei Zhaqu Yin on COXI mRNA and its protein in non-alcoholic fatty liver disease rats","volume":"41","author":"Zhang","year":"2014","journal-title":"Liaoning J Tradit Chin Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"149403","DOI":"10.1016\/j.ijbiomac.2025.149403","article-title":"Recent advances in hawthorn (Crataegus L.) polysaccharides for prevention and treatment of non-alcoholic fatty liver disease (NAFLD): a review","volume":"336","author":"Li","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"120991","DOI":"10.1016\/j.jep.2025.120991","article-title":"Hawthorn juice transforms notoginseng stem-leaf saponins: synergistically regulates blood viscosity and ameliorates glycolipid metabolic disorders","volume":"358","author":"Lin","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"117647","DOI":"10.1016\/j.jep.2023.117647","article-title":"Protective effects of Huang-Qi-Ge-gen decoction against diabetic liver injury through regulating PI3K\/AKT\/Nrf2 pathway and metabolic profiling","volume":"323","author":"Zhang","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s11655-025-3836-7","article-title":"Huanglian Jiedu decoction alleviates metabolic-associated fatty liver disease in vivo and in vitro via IRE1\u03b1\/XBP1s signaling pathway","volume":"32","author":"Zheng","year":"2026","journal-title":"Chin J Integr Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"155437","DOI":"10.1016\/j.phymed.2024.155437","article-title":"Rutin ameliorated lipid metabolism dysfunction of diabetic NAFLD via AMPK\/SREBP1 pathway","volume":"126","author":"Liu","year":"2024","journal-title":"Phytomedicine"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/07435800.2023.2278049","article-title":"Animal models of type 2 diabetes complications: a review","volume":"49","author":"Sun","year":"2024","journal-title":"Endocr Res"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/hep.31220","article-title":"N6 -methyladenosine reader protein YT521-B homology domain-containing 2 suppresses liver steatosis by regulation of mRNA stability of lipogenic genes","volume":"73","author":"Zhou","year":"2021","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41575-020-00406-0","article-title":"Nonalcoholic fatty liver disease: another leap forward","volume":"18","author":"Abdelmalek","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e2000375","DOI":"10.1002\/mnfr.202000375","article-title":"The gut microbiota and its metabolites, novel targets for treating and preventing non-alcoholic fatty liver disease","volume":"64","author":"Ni","year":"2020","journal-title":"Mol Nutr Food Res"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jmb.2018.01.010","article-title":"Molecular paths linking metabolic diseases, gut microbiota dysbiosis and enterobacteria infections","volume":"430","author":"Serino","year":"2018","journal-title":"J Mol Biol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.clinbiochem.2015.06.023","article-title":"Gut-liver axis, nutrition, and non-alcoholic fatty liver disease","volume":"48","author":"Kirpich","year":"2015","journal-title":"Clin Biochem"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"155142","DOI":"10.1016\/j.metabol.2022.155142","article-title":"Insulin: the master regulator of glucose metabolism","volume":"129","author":"Norton","year":"2022","journal-title":"Metabolism"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.3390\/cimb43030128","article-title":"Losartan attenuates insulin resistance and regulates Browning phenomenon of white adipose tissue in Ob\/Ob mice","volume":"43","author":"Liu","year":"2021","journal-title":"Curr Issues Mol Biol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"8418","DOI":"10.1097\/MS9.0000000000004012","article-title":"Diabetes and liver cirrhosis: shared pathways and clinical implications\u2014a narrative review","volume":"87","author":"Mohan","year":"2025","journal-title":"Ann Med Surg (Lond)"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/liv.13337","article-title":"Hepatogenous diabetes: is it time to separate it from type 2 diabetes?","volume":"37","author":"Orsi","year":"2017","journal-title":"Liver Int"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"157409","DOI":"10.1016\/j.phymed.2025.157409","article-title":"Oral rhein attenuate nonalcoholic steatohepatitis in mice through the modulation of gut microbiota and Th17 cell differentiation","volume":"148","author":"Yuan","year":"2025","journal-title":"Phytomedicine"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/gutjnl-2022-328515","article-title":"Irritable bowel syndrome: treatment based on pathophysiology and biomarkers","volume":"72","author":"Camilleri","year":"2023","journal-title":"Gut"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1126\/science.aao5774","article-title":"Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes","volume":"359","author":"Zhao","year":"2018","journal-title":"Science"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1017\/jns.2016.12","article-title":"Lactobacillus gasseri SBT2055 inhibits adipose tissue inflammation and intestinal permeability in mice fed a high-fat diet","volume":"5","author":"Kawano","year":"2016","journal-title":"J Nutr Sci"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.3390\/nu16162660","article-title":"Exploration of the Muribaculaceae family in the gut microbiota: diversity, metabolism, and function","volume":"16","author":"Zhu","year":"2024","journal-title":"Nutrients"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.3390\/nu15133033","article-title":"Protective effects of white kidney bean (Phaseolus vulgaris L.) against diet-induced hepatic steatosis in mice are linked to modification of gut microbiota and its metabolites","volume":"15","author":"Feng","year":"2023","journal-title":"Nutrients"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","article-title":"Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s40104-025-01284-9","article-title":"Advances in understanding the role of gut microbiota in fat deposition and lipid metabolism","volume":"16","author":"Zhong","year":"2025","journal-title":"J Anim Sci Biotechnol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.cmet.2012.01.024","article-title":"Interplay between lipids and branched-chain amino acids in development of insulin resistance","volume":"15","author":"Newgard","year":"2012","journal-title":"Cell Metab"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41579-025-01183-w","article-title":"Gut microbiota-derived short-chain fatty acids and their role in human health and disease","volume":"23","author":"Mukhopadhya","year":"2025","journal-title":"Nat Rev Microbiol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3390\/nu11030705","article-title":"Non-alcoholic fatty liver disease and risk of incident type 2 diabetes: role of circulating branched-chain amino acids","volume":"11","author":"van den Berg","year":"2019","journal-title":"Nutrients"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"110161","DOI":"10.1016\/j.jnutbio.2025.110161","article-title":"Hepatic lipidomics reveals lipid metabolism reprogramming response to different branched-chain amino acids interventions in nonalcoholic fatty liver disease of laying hens","volume":"148","author":"Jian","year":"2026","journal-title":"J Nutr Biochem"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1161\/CIRCRESAHA.112.268276","article-title":"Glycine normalizes hepatic triglyceride-rich VLDL secretion by triggering the CNS in high-fat fed rats","volume":"110","author":"Yue","year":"2012","journal-title":"Circ Res"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"eaaz2841","DOI":"10.1126\/scitranslmed.aaz2841","article-title":"Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome","volume":"12","author":"Rom","year":"2020","journal-title":"Sci Transl Med"},{"key":"ref46","first-page":"10261","article-title":"Glycine protects against non-alcoholic hepatitis by downregulation of the TLR4 signaling pathway","volume":"10","author":"Yang","year":"2017","journal-title":"Int J Clin Exp Pathol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.1021\/acs.jmedchem.3c00067","article-title":"Discovery of the first raptor (regulatory-associated protein of mTOR) inhibitor as a new type of antiadipogenic agent","volume":"66","author":"Yan","year":"2023","journal-title":"J Med Chem"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1007\/s11064-020-03090-3","article-title":"Phosphorylation of 5-LOX: the potential set-point of inflammation","volume":"45","author":"He","year":"2020","journal-title":"Neurochem Res"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.3945\/an.116.012245","article-title":"The role of cytochrome P450 Epoxygenases, soluble epoxide hydrolase, and Epoxyeicosatrienoic acids in metabolic diseases","volume":"7","author":"Xu","year":"2016","journal-title":"Adv Nutr"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1039\/C7MB00013H","article-title":"Systems-level organization of non-alcoholic fatty liver disease progression network","volume":"13","author":"Shubham","year":"2017","journal-title":"Mol BioSyst"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.3390\/cells9112367","article-title":"The role of PPARs in disease","volume":"9","author":"Wagner","year":"2020","journal-title":"Cells"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"e89969","DOI":"10.7759\/cureus.89969","article-title":"Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis: a systematic review","volume":"17","author":"Ahmed","year":"2025","journal-title":"Cureus"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"118264","DOI":"10.1016\/j.ejmech.2025.118264","article-title":"Structural and functional insights into PPAR-\u03b3: review of its potential and drug design innovations for the development of antidiabetic agents","volume":"302","author":"Gupta","year":"2026","journal-title":"Eur J Med Chem"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1172\/JCI119424","article-title":"Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids","volume":"99","author":"Vidal-Puig","year":"1997","journal-title":"J Clin Invest"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"107080","DOI":"10.1016\/j.fitote.2025.107080","article-title":"Gardenia jasminoides Ellis polysaccharides improve gut microbiota disorder and glucose homeostasis in type 2 diabetic mice","volume":"189","author":"Lu","year":"2026","journal-title":"Fitoterapia"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"120923","DOI":"10.1016\/j.jep.2025.120923","article-title":"Divergent roles of crassifolin B and cyperenoic acid from Gentiana kurroo in regulating adipocyte differentiation in 3T3-L1 cells through PPAR\u03b3 and MAPK pathways","volume":"357","author":"Nishina","year":"2026","journal-title":"J Ethnopharmacol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.3390\/nu17162665","article-title":"Liubao tea extract attenuates high-fat diet and streptozotocin-induced type 2 diabetes in mice by remodeling hepatic metabolism and gut microbiota","volume":"17","author":"Luo","year":"2025","journal-title":"Nutrients"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"114720","DOI":"10.1016\/j.phytochem.2025.114720","article-title":"Scutellaria baicalensis extract prevents metabolic dysfunction-associated steatotic liver disease by modulating the gut-liver axis in high-fat diet mice","volume":"243","author":"Ma","year":"2025","journal-title":"Phytochemistry"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"8846","DOI":"10.1002\/fsn3.4449","article-title":"Isoxanthohumol improves hepatic lipid metabolism via regulating the AMPK\/PPAR\u03b1 and PI3K\/AKT signaling pathways in hyperlipidemic mice","volume":"12","author":"Gao","year":"2024","journal-title":"Food Sci Nutr"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1007\/s10787-024-01472-5","article-title":"Therapeutic effects and mechanisms of isoxanthohumol on DSS-induced colitis: regulating T cell development, restoring gut microbiota, and improving metabolic disorders","volume":"32","author":"Yang","year":"2024","journal-title":"Inflammopharmacology"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"100","DOI":"10.12938\/bmfh.2019-045","article-title":"Isoxanthohumol, a hop-derived flavonoid, alters the metabolomics profile of mouse feces","volume":"39","author":"Fukizawa","year":"2020","journal-title":"Biosci Microbiota Food Health"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"101797","DOI":"10.1016\/j.molmet.2023.101797","article-title":"Isoxanthohumol improves obesity and glucose metabolism via inhibiting intestinal lipid absorption with a bloom of Akkermansia muciniphila in mice","volume":"77","author":"Watanabe","year":"2023","journal-title":"Mol Metab"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1775686\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T15:22:03Z","timestamp":1774624923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1775686\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":62,"alternative-id":["10.3389\/fnut.2026.1775686"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1775686","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"article-number":"1775686"}}